Skip to content

Clinical trials

Anorexia Nervosa trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Anorexia Nervosa Country / region: United States Clear all

170 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20004
20021
20034
20046
20056
20066
20075
20087
20098
20104
20113
20122
20135
20142
20156
201610
20175
20186
20197
20208
20218
202215
202314
202413
20255
20267

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed114
Recruiting27
Terminated7
Active, not recruiting6
Unknown status5
Not yet recruiting4
Withdrawn4
Enrolling by invitation3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
New York State Psychiatric Institute20
University of California, San Diego19
Massachusetts General Hospital16
Stanford University11
University of North Carolina, Chapel Hill8
University of Louisville7
Laureate Institute for Brain Research, Inc.6
University of California, San Francisco6
University of Minnesota6
Icahn School of Medicine at Mount Sinai5

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Anorexia Nervosa170
Feeding and Eating Disorders73
Bulimia Nervosa32
Binge-Eating Disorder14
Anorexia13
Bulimia11
Anxiety Disorders10
Avoidant Restrictive Food Intake Disorder6
Bone Diseases, Metabolic6
Osteoporosis6

Trials

Showing 1 to 25 of 170. Each trial links to its page on Pharma Observatory.

70 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.